470 related articles for article (PubMed ID: 16734725)
1. Possible tumor development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis.
Kitano M; Wada J; Ariki Y; Kato M; Wanibuchi H; Morimura K; Hidaka T; Hosoe K; Fukushima S
Cancer Sci; 2006 Jun; 97(6):478-83. PubMed ID: 16734725
[TBL] [Abstract][Full Text] [Related]
2. Chronic ethanol intake promotes double gluthatione S-transferase/transforming growth factor-alpha-positive hepatocellular lesions in male Wistar rats.
Pires PW; Furtado KS; Justullin LA; Rodrigues MA; Felisbino SL; Barbisan LF
Cancer Sci; 2008 Feb; 99(2):221-8. PubMed ID: 18271918
[TBL] [Abstract][Full Text] [Related]
3. Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats.
Mizukami S; Ichimura R; Kemmochi S; Taniai E; Shimamoto K; Ohishi T; Takahashi M; Mitsumori K; Shibutani M
Arch Toxicol; 2010 Apr; 84(4):319-31. PubMed ID: 20091025
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of Ginkgo biloba against rat liver carcinogenesis.
Dias MC; Rodrigues MA; Reimberg MC; Barbisan LF
Chem Biol Interact; 2008 May; 173(1):32-42. PubMed ID: 18367157
[TBL] [Abstract][Full Text] [Related]
5. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
[TBL] [Abstract][Full Text] [Related]
6. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
Kitano M; Ichihara T; Matsuda T; Wanibuchi H; Tamano S; Hagiwara A; Imaoka S; Funae Y; Shirai T; Fukushima S
Carcinogenesis; 1998 Aug; 19(8):1475-80. PubMed ID: 9744545
[TBL] [Abstract][Full Text] [Related]
7. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes.
Puatanachokchai R; Morimura K; Wanibuchi H; Oka M; Kinoshita A; Mitsuru F; Yamaguchi S; Funae Y; Fukushima S
Cancer Lett; 2006 Aug; 240(1):102-13. PubMed ID: 16246485
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model.
Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Kenmochi S; Shimamoto K; Harada T; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Feb; 85(2):155-62. PubMed ID: 20502879
[TBL] [Abstract][Full Text] [Related]
9. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
[TBL] [Abstract][Full Text] [Related]
10. Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats.
Nishimura J; Dewa Y; Okamura T; Jin M; Saegusa Y; Kawai M; Umemura T; Shibutani M; Mitsumori K
Toxicol Sci; 2008 Dec; 106(2):339-49. PubMed ID: 18775883
[TBL] [Abstract][Full Text] [Related]
11. Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis.
Fan Y; Shimizu T; Yamada T; Nanashima N; Akita M; Asano J; Tsuchida S
Cancer Sci; 2008 Mar; 99(3):497-501. PubMed ID: 18081878
[TBL] [Abstract][Full Text] [Related]
12. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
Steinmetz KL; Klaunig JE
Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
[TBL] [Abstract][Full Text] [Related]
15. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
[TBL] [Abstract][Full Text] [Related]
16. An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation.
Kagawa M; Sano T; Ishibashi N; Hashimoto M; Okuno M; Moriwaki H; Suzuki R; Kohno H; Tanaka T
Carcinogenesis; 2004 Jun; 25(6):979-85. PubMed ID: 14742314
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.
Shimizu T; Fan Y; Yamana D; Miura T; Nanashima N; Yamada T; Tsuchida S
Cancer Sci; 2010 May; 101(5):1093-8. PubMed ID: 20180811
[TBL] [Abstract][Full Text] [Related]
18. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
[TBL] [Abstract][Full Text] [Related]
19. Indole-3-carbinol enhances oxidative stress responses resulting in the induction of preneoplastic liver cell lesions in partially hepatectomized rats initiated with diethylnitrosamine.
Shimamoto K; Dewa Y; Ishii Y; Kemmochi S; Taniai E; Hayashi H; Imaoka M; Morita R; Kuwata K; Suzuki K; Shibutani M; Mitsumori K
Toxicology; 2011 May; 283(2-3):109-17. PubMed ID: 21396975
[TBL] [Abstract][Full Text] [Related]
20. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
